(Q43749263)

26 November 2017

Leukopenia predicts remission in patients with inflammatory bowel disease and Behcet's disease on thiopurine maintenance (English)

1 reference

inflammatory bowel diseases

26 November 2017

0 references

1 reference

8

1 reference

26 November 2017

Mi Sung Park

1

1 reference

26 November 2017

Dong Hyun Kim

2

1 reference

26 November 2017

Duk Hwan Kim

3

1 reference

26 November 2017

Soo Jung Park

4

1 reference

26 November 2017

Sung Pil Hong

5

1 reference

26 November 2017

Tae Il Kim

6

1 reference

26 November 2017

Won Ho Kim

7

1 reference

26 November 2017

20 September 2014

1 reference

Digestive Diseases and Sciences

26 November 2017

1 reference

26 November 2017

60

1 reference

26 November 2017

1

1 reference

26 November 2017

195-204

1 reference

https://scigraph.springernature.com/pub.10.1007/s10620-014-3355-4

26 November 2017

0 references

cites work

Disease activity courses in a regional cohort of Crohn's disease patients.

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3355-4

THE COURSE AND PROGNOSIS OF ULCERATIVE COLITIS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3355-4

Epidemiology of inflammatory bowel disease in the Songpa-Kangdong district, Seoul, Korea, 1986-2005: a KASID study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3355-4

Inflammatory bowel disease in Korea: epidemiological, genomic, clinical, and therapeutic characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3355-4

The clinical significance of a pathergy reaction in patients with Behcet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3355-4

Long-term evolution of disease behavior of Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3355-4

Gastrointestinal manifestations of Behçet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3355-4

The efficacy of azathioprine for the treatment of inflammatory bowel disease: a 30 year review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3355-4

Azathioprine in inflammatory bowel disease, a safe alternative?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3355-4

Thiopurine-induced myelotoxicity in patients with inflammatory bowel disease: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3355-4

American Gastroenterological Association Institute technical review on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3355-4

Safety of azathioprine and 6-mercaptopurine in pediatric patients with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3355-4

Bone marrow toxicity caused by azathioprine in inflammatory bowel disease: 27 years of experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3355-4

Rational dosing of azathioprine and 6-mercaptopurine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3355-4

Thiopurine methyltransferase (TPMT) activity and adverse effects of azathioprine in inflammatory bowel disease: long-term follow-up study of 394 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3355-4

Correlation of genotypes for thiopurine methyltransferase and inosine triphosphate pyrophosphatase with long-term clinical outcomes in Korean patients with inflammatory bowel diseases during treatment with thiopurine drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3355-4

Development and validation of novel diagnostic criteria for intestinal Behçet's disease in Korean patients with ileocolonic ulcers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3355-4

European evidence-based Consensus on the diagnosis and management of ulcerative colitis: Definitions and diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3355-4

Outcome predictors for thiopurine maintenance therapy in patients with Crohn's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3355-4

A case of Crohn's disease with improvement after azathioprine-induced pancytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3355-4

Comparison of leukocyte excretion and blood loss in inflammatory disease of the bowel

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3355-4

Is neutropenia required for effective maintenance of remission during azathioprine therapy in inflammatory bowel disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3355-4

Neutropenia is not required for clinical remission during azathioprine therapy in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3355-4

5-aminosalicylate therapy is associated with higher 6-thioguanine levels in adults and children with inflammatory bowel disease in remission on 6-mercaptopurine or azathioprine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3355-4

Leucopenia resulting from a drug interaction between azathioprine or 6-mercaptopurine and mesalamine, sulphasalazine, or balsalazide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3355-4

Identifying patients with a high risk of relapse in quiescent Crohn's disease. The GETAID Group. The Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3355-4

The immunological and genetic basis of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3355-4

Immunity, inflammation, and allergy in the gut.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3355-4

The immune system in the elderly: II. Specific cellular immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3355-4

Low-dose azathioprine is effective and safe for maintenance of remission in patients with ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3355-4

Thiopurine therapy in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3355-4

Patientsʼ attitudes to medicines and adherence to maintenance treatment in inflammatory bowel disease

21 January 2018

1 reference

12 December 2020

Ulcerative colitis: prolonged remission following azathioprine-induced pancytopenia.

1 reference

12 December 2020

Risk factors for non-adherence to medication in inflammatory bowel disease patients

1 reference

12 December 2020

Classification of inflammatory bowel disease

1 reference

12 December 2020

Optimum duration of treatment with 6-mercaptopurine for Crohn's disease

1 reference

12 December 2020

6-Mercaptopurine in the management of inflammatory bowel disease: short- and long-term toxicity

1 reference

12 December 2020

[The frequency and the course of the adverse effects of azathioprine/6-mercaptopurine treatment in patients with inflammatory bowel disease]

1 reference

12 December 2020

The role of leukopenia in the 6-mercaptopurine-induced remission of refractory Crohn's disease

1 reference

12 December 2020

Development of consensus statements for the diagnosis and management of intestinal Behçet's disease using a modified Delphi approach

1 reference

12 December 2020

Azathioprine and 6-mercaptopurine in Crohn disease. A meta-analysis

1 reference

12 December 2020

Azathioprine and 6-mercaptopurine for maintenance of remission in ulcerative colitis

1 reference

12 December 2020

Azathioprine for maintaining remission of Crohn's disease

1 reference

12 December 2020

Significance of WBC differential when leukopenia is induced by 6-MP for IBD

1 reference

12 December 2020

A multicenter trial of 6-mercaptopurine and prednisone in children with newly diagnosed Crohn's disease

1 reference

12 December 2020

Clinical outcomes and prognostic factors for thiopurine maintenance therapy in patients with intestinal Behcet's disease

1 reference

12 December 2020

Epidemiology of inflammatory bowel disease

1 reference

12 December 2020

Influences of thiopurine methyltransferase genotype and activity on thiopurine-induced leukopenia in Korean patients with inflammatory bowel disease: a retrospective cohort study

1 reference

12 December 2020

10.1007/S10620-014-3355-4

Identifiers

DOI

1 reference

26 November 2017

1 reference